Cargando…

Symptom Management for Patients With Esophageal Cancer After Esophagectomy

CASE STUDY KD is a 67-year-old man with a medical history of hypertension, asthma, and a 20-pack/year smoking history who developed progressive dysphagia 8 months ago. Upon consultation with his primary care provider, he underwent an esophagogastroduodenoscopy (EGD) for evaluation. A friable mass wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachella, Laura A., Knippel, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902153/
https://www.ncbi.nlm.nih.gov/pubmed/29670809
_version_ 1783314719214403584
author Pachella, Laura A.
Knippel, Susan
author_facet Pachella, Laura A.
Knippel, Susan
author_sort Pachella, Laura A.
collection PubMed
description CASE STUDY KD is a 67-year-old man with a medical history of hypertension, asthma, and a 20-pack/year smoking history who developed progressive dysphagia 8 months ago. Upon consultation with his primary care provider, he underwent an esophagogastroduodenoscopy (EGD) for evaluation. A friable mass was visualized at the gastroesophageal junction, and biopsies confirmed adenocarcinoma of the esophagus. KD completed a staging evaluation with positron-emission tomography/computed tomography (PET/CT), which did not reveal distant metastatic disease. He also had an endoscopic ultrasound (EUS), which showed the tumor invading the muscularis propria and did not identify any enlarged regional lymph nodes (stage T3N0 disease). KD was referred to a medical oncologist and a radiation oncologist; he underwent concurrent chemoradiation therapy with docetaxel and fluorouracil and radiation therapy (50.4 Gy). KD was referred to thoracic surgery following restaging with PET/CT and EGD; there was no evidence of distant metastatic disease, and pathology findings revealed residual adenocarcinoma in one of the four esophageal biopsies. KD underwent Ivor Lewis esophagectomy and had a jejunostomy tube placed for nutritional requirements for 10 weeks as he adjusted to oral nutrition. Surgical pathology findings revealed residual adenocarcinoma with treatment effect; no malignancy was detected in the sampled regional lymph nodes. Four months later, KD presents with complaints of frequent postprandial diarrhea and reflux. He says he has been trying to lie down after meals due to palpitations and flushing. He is anxious about these symptoms and fearful about his long-term prognosis adjusting to the side effects of esophagectomy and would like to discuss lifestyle modifications.
format Online
Article
Text
id pubmed-5902153
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-59021532018-04-18 Symptom Management for Patients With Esophageal Cancer After Esophagectomy Pachella, Laura A. Knippel, Susan J Adv Pract Oncol Review Article CASE STUDY KD is a 67-year-old man with a medical history of hypertension, asthma, and a 20-pack/year smoking history who developed progressive dysphagia 8 months ago. Upon consultation with his primary care provider, he underwent an esophagogastroduodenoscopy (EGD) for evaluation. A friable mass was visualized at the gastroesophageal junction, and biopsies confirmed adenocarcinoma of the esophagus. KD completed a staging evaluation with positron-emission tomography/computed tomography (PET/CT), which did not reveal distant metastatic disease. He also had an endoscopic ultrasound (EUS), which showed the tumor invading the muscularis propria and did not identify any enlarged regional lymph nodes (stage T3N0 disease). KD was referred to a medical oncologist and a radiation oncologist; he underwent concurrent chemoradiation therapy with docetaxel and fluorouracil and radiation therapy (50.4 Gy). KD was referred to thoracic surgery following restaging with PET/CT and EGD; there was no evidence of distant metastatic disease, and pathology findings revealed residual adenocarcinoma in one of the four esophageal biopsies. KD underwent Ivor Lewis esophagectomy and had a jejunostomy tube placed for nutritional requirements for 10 weeks as he adjusted to oral nutrition. Surgical pathology findings revealed residual adenocarcinoma with treatment effect; no malignancy was detected in the sampled regional lymph nodes. Four months later, KD presents with complaints of frequent postprandial diarrhea and reflux. He says he has been trying to lie down after meals due to palpitations and flushing. He is anxious about these symptoms and fearful about his long-term prognosis adjusting to the side effects of esophagectomy and would like to discuss lifestyle modifications. Harborside Press 2016 2016-11-01 /pmc/articles/PMC5902153/ /pubmed/29670809 Text en Copyright © 2016, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Pachella, Laura A.
Knippel, Susan
Symptom Management for Patients With Esophageal Cancer After Esophagectomy
title Symptom Management for Patients With Esophageal Cancer After Esophagectomy
title_full Symptom Management for Patients With Esophageal Cancer After Esophagectomy
title_fullStr Symptom Management for Patients With Esophageal Cancer After Esophagectomy
title_full_unstemmed Symptom Management for Patients With Esophageal Cancer After Esophagectomy
title_short Symptom Management for Patients With Esophageal Cancer After Esophagectomy
title_sort symptom management for patients with esophageal cancer after esophagectomy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902153/
https://www.ncbi.nlm.nih.gov/pubmed/29670809
work_keys_str_mv AT pachellalauraa symptommanagementforpatientswithesophagealcancerafteresophagectomy
AT knippelsusan symptommanagementforpatientswithesophagealcancerafteresophagectomy